BLOG

Thursday, June 20, 2019

Aurobindo Pharma slips 8% on USFDA warning for Andhra Pradesh facility

The company said it believes the existing business from this facility will not be impacted

from Home Page http://bit.ly/2x6OASf
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...